Early Success for New Postmenopausal Osteoporosis Treatment
Investigators at the Sahlgrenska Academy at Göteborg University in Gothenburg, Sweden, discovered a possible new method for treating the osteoporosis associated with postmenopausal RA.
Explore this issueDecember 2007
New treatments alternatives are important since hormone replacement therapy with estrogen—the standard osteoporosis treatment—has recently been shown to have significant side effects.
Investigators began with a well-studied model of post-menopausal RA in mice. They then used raloxifene, a selective estrogen receptor modulator (SERM), to stimulate estrogen-like action.